433 related articles for article (PubMed ID: 26776090)
1. Variants in the SNCA gene associate with motor progression while variants in the MAPT gene associate with the severity of Parkinson's disease.
Wang G; Huang Y; Chen W; Chen S; Wang Y; Xiao Q; Liu J; Fung VS; Halliday G; Chen S
Parkinsonism Relat Disord; 2016 Mar; 24():89-94. PubMed ID: 26776090
[TBL] [Abstract][Full Text] [Related]
2. SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians.
Huang Y; Wang G; Rowe D; Wang Y; Kwok JB; Xiao Q; Mastaglia F; Liu J; Chen SD; Halliday G
Biomed Res Int; 2015; 2015():135674. PubMed ID: 25960998
[TBL] [Abstract][Full Text] [Related]
3. Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.
Elbaz A; Ross OA; Ioannidis JP; Soto-Ortolaza AI; Moisan F; Aasly J; Annesi G; Bozi M; Brighina L; Chartier-Harlin MC; Destée A; Ferrarese C; Ferraris A; Gibson JM; Gispert S; Hadjigeorgiou GM; Jasinska-Myga B; Klein C; Krüger R; Lambert JC; Lohmann K; van de Loo S; Loriot MA; Lynch T; Mellick GD; Mutez E; Nilsson C; Opala G; Puschmann A; Quattrone A; Sharma M; Silburn PA; Stefanis L; Uitti RJ; Valente EM; Vilariño-Güell C; Wirdefeldt K; Wszolek ZK; Xiromerisiou G; Maraganore DM; Farrer MJ;
Ann Neurol; 2011 May; 69(5):778-92. PubMed ID: 21391235
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.
Heckman MG; Elbaz A; Soto-Ortolaza AI; Serie DJ; Aasly JO; Annesi G; Auburger G; Bacon JA; Boczarska-Jedynak M; Bozi M; Brighina L; Chartier-Harlin MC; Dardiotis E; Destée A; Ferrarese C; Ferraris A; Fiske B; Gispert S; Hadjigeorgiou GM; Hattori N; Ioannidis JP; Jasinska-Myga B; Jeon BS; Kim YJ; Klein C; Kruger R; Kyratzi E; Lin CH; Lohmann K; Loriot MA; Lynch T; Mellick GD; Mutez E; Opala G; Park SS; Petrucci S; Quattrone A; Sharma M; Silburn PA; Sohn YH; Stefanis L; Tadic V; Tomiyama H; Uitti RJ; Valente EM; Vassilatis DK; Vilariño-Güell C; White LR; Wirdefeldt K; Wszolek ZK; Wu RM; Xiromerisiou G; Maraganore DM; Farrer MJ; Ross OA;
Neurobiol Aging; 2014 Jan; 35(1):266.e5-14. PubMed ID: 23962496
[TBL] [Abstract][Full Text] [Related]
5. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study.
Wider C; Vilariño-Güell C; Heckman MG; Jasinska-Myga B; Ortolaza-Soto AI; Diehl NN; Crook JE; Cobb SA; Bacon JA; Aasly JO; Gibson JM; Lynch T; Uitti RJ; Wszolek ZK; Farrer MJ; Ross OA
Eur J Neurol; 2011 Jun; 18(6):876-81. PubMed ID: 21159074
[TBL] [Abstract][Full Text] [Related]
6. Assessment of risk factor variants of LRRK2, MAPT, SNCA and TCEANC2 genes in Hungarian sporadic Parkinson's disease patients.
Boros FA; Török R; Vágvölgyi-Sümegi E; Pesei ZG; Klivényi P; Vécsei L
Neurosci Lett; 2019 Jul; 706():140-145. PubMed ID: 31085292
[TBL] [Abstract][Full Text] [Related]
7. SNCA rs11931074 polymorphism correlates with spontaneous brain activity and motor symptoms in Chinese patients with Parkinson's disease.
Si QQ; Yuan YS; Zhi Y; Wang M; Wang JW; Shen YT; Wang LN; Li JY; Wang XX; Zhang KZ
J Neural Transm (Vienna); 2019 Aug; 126(8):1037-1045. PubMed ID: 31243602
[TBL] [Abstract][Full Text] [Related]
8. Does α-synuclein have a dual and opposing effect in preclinical vs. clinical Parkinson's disease?
Markopoulou K; Biernacka JM; Armasu SM; Anderson KJ; Ahlskog JE; Chase BA; Chung SJ; Cunningham JM; Farrer M; Frigerio R; Maraganore DM
Parkinsonism Relat Disord; 2014 Jun; 20(6):584-9; discussion 584. PubMed ID: 24656894
[TBL] [Abstract][Full Text] [Related]
9. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
[TBL] [Abstract][Full Text] [Related]
10. SNCA and MAPT genes: Independent and joint effects in Parkinson disease in the Italian population.
Trotta L; Guella I; Soldà G; Sironi F; Tesei S; Canesi M; Pezzoli G; Goldwurm S; Duga S; Asselta R
Parkinsonism Relat Disord; 2012 Mar; 18(3):257-62. PubMed ID: 22104010
[TBL] [Abstract][Full Text] [Related]
11. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
[TBL] [Abstract][Full Text] [Related]
12. APOE, MAPT, and SNCA genes and cognitive performance in Parkinson disease.
Mata IF; Leverenz JB; Weintraub D; Trojanowski JQ; Hurtig HI; Van Deerlin VM; Ritz B; Rausch R; Rhodes SL; Factor SA; Wood-Siverio C; Quinn JF; Chung KA; Peterson AL; Espay AJ; Revilla FJ; Devoto J; Hu SC; Cholerton BA; Wan JY; Montine TJ; Edwards KL; Zabetian CP
JAMA Neurol; 2014 Nov; 71(11):1405-12. PubMed ID: 25178429
[TBL] [Abstract][Full Text] [Related]
13. Interaction between α-synuclein and tau genotypes and the progression of Parkinson's disease.
Huang Y; Rowe DB; Halliday GM
J Parkinsons Dis; 2011; 1(3):271-6. PubMed ID: 23939307
[TBL] [Abstract][Full Text] [Related]
14. Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?
Biernacka JM; Armasu SM; Cunningham JM; Ahlskog JE; Chung SJ; Maraganore DM
Parkinsonism Relat Disord; 2011 Dec; 17(10):730-6. PubMed ID: 21816655
[TBL] [Abstract][Full Text] [Related]
15. Risk variants of the α-synuclein locus and REM sleep behavior disorder in Parkinson's disease: a genetic association study.
Bjørnarå KA; Pihlstrøm L; Dietrichs E; Toft M
BMC Neurol; 2018 Feb; 18(1):20. PubMed ID: 29466944
[TBL] [Abstract][Full Text] [Related]
16. Replication of MAPT and SNCA, but not PARK16-18, as susceptibility genes for Parkinson's disease.
Mata IF; Yearout D; Alvarez V; Coto E; de Mena L; Ribacoba R; Lorenzo-Betancor O; Samaranch L; Pastor P; Cervantes S; Infante J; Garcia-Gorostiaga I; Sierra M; Combarros O; Snapinn KW; Edwards KL; Zabetian CP
Mov Disord; 2011 Apr; 26(5):819-23. PubMed ID: 21425343
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
Ritz B; Rhodes SL; Bordelon Y; Bronstein J
PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
[TBL] [Abstract][Full Text] [Related]
18. Lack of interaction of SNCA and MAPT genotypes in Parkinson's disease.
Botta-Orfila T; Ezquerra M; Ríos J; Fernández-Santiago R; Cervantes S; Samaranch L; Pastor P; Martí MJ; Muñoz E; Valldeoriola F; Aguilar M; Calopa M; Hernández-Vara J; Tolosa E
Eur J Neurol; 2011 Mar; 18(3):e32. PubMed ID: 21054681
[No Abstract] [Full Text] [Related]
19. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
20. Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson's disease.
Chen W; Kang WY; Chen S; Wang Y; Xiao Q; Wang G; Liu J; Chen SD
Parkinsonism Relat Disord; 2015 Jun; 21(6):610-4. PubMed ID: 25921825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
